<DOC>
	<DOC>NCT01022801</DOC>
	<brief_summary>To demonstrate the dose response of entecavir in Japanese patients as measured by HBV DNA levels by PCR (log10 copies/mL) at Week 22</brief_summary>
	<brief_title>A Phase II Dose Response Study in Japan in Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Positive for HBsAg OR, negative for IgM core antibody and confirmation of chronic hepatitis B on liver biopsy, Positive for HBeAg OR negative for HBeAg with positive HBeAb, Documented HBV Viremia on 2 or more occasions: Viremia on sample drawn AND HBV DNA of â‰¥ 40 MEq/mL by Quantiplex assay at the screening visit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>